Condition
Cognitive Decline, Mild
Total Trials
4
Recruiting
2
Active
2
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 2 (1)
Trial Status
Recruiting2
Completed2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06362707Phase 2RecruitingPrimary
Fasudil Trial for Treatment of Early Alzheimer's Disease (FEAD)
NCT06495190Not ApplicableRecruitingPrimary
Cognition, Flavonoids, Exercise, Gut Microbiome
NCT05983913Not ApplicableCompletedPrimary
Effects of Wearable Sensor-based Interactive Cognitive-motor Training in Older Adults.
NCT04939961Not ApplicableCompletedPrimary
Effects of Hericium Erinaceus on Microbiota and Cognition
Showing all 4 trials